NCT05130476

Brief Summary

The parathyroid glands and their blood vessels are notoriously difficult to visualize and may therefore be unintentionally and irrevocably damaged during thyroid surgery. This project investigates new surgeon-performed imaging techniques that visualize the parathyroid glands and their vessels in real-time during thyroid surgery. The purpose is to examine, in a matched cohort study, whether the implementation of near-infrared-induced autofluorescence for identification of the parathyroid glands, combined with indocyanine green near-infrared angiography of the parathyroid feeding vessels, can reduce the incidence of postoperative hypocalcaemia in patients undergoing total and completion thyroidectomy at Odense University Hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 8, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 23, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 13, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2024

Completed
Last Updated

January 16, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

November 8, 2021

Last Update Submit

January 14, 2025

Conditions

Keywords

Near-infrared fluorescence

Outcome Measures

Primary Outcomes (1)

  • Permanent hypoparathyroidism 12 months after surgery

    The number of participants in the study cohort with permanent hypoparathyroidism 12 months after treatment compared to the number of participants with permanent hypoparathyroidism 12 months after treatment in a matched retrospective cohort from the same hospital that underwent surgery without NIRAF+ICGA.

    12 months postoperatively

Study Arms (1)

NIRAF+ICGA

EXPERIMENTAL

During thyroid surgery, near-infrared-induced autofluorescence is used for the identification of the parathyroid glands, combined with indocyanine green near-infrared angiography for identification of the parathyroid feeding vessels.

Procedure: Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography

Interventions

During thyroid surgery, near-infrared-induced autofluorescence is used for the identification of the parathyroid glands, combined with indocyanine green near-infrared angiography for identification of the parathyroid feeding vessels.

NIRAF+ICGA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years and older who are scheduled to undergo total or completion thyroidectomy at the department of Oro-Rhino-Laryngology (ORL) and Head and Neck Surgery at Odense University Hospital, Denmark.

You may not qualify if:

  • Not legally competent.
  • Does not read or speak Danish.
  • Is pregnant or nursing.
  • Suffers from chronic kidney disease with an estimated glomerular filtration rate \< 45 ml/min/1.73m2.
  • Has a history of allergy to iodides or to indocyanine green.
  • Suffers from hyperparathyroidism, hypoparathyroidism, or hypocalcaemia prior to surgery.
  • Prescription use of supplemental active vitamin D: dihydrotachysterol (ATC 11CC02), alfacalcidol (ATC A11CC03), or calcitriol (ATC A11CC04).
  • Patients scheduled to have a radioactive iodine uptake study performed ≤ 7 days after the thyroidectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense C, 5000, Denmark

Location

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Matched cohort study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 8, 2021

First Posted

November 23, 2021

Study Start

October 1, 2021

Primary Completion

October 13, 2023

Study Completion

November 20, 2024

Last Updated

January 16, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations